SVRA
Savara Inc
NASDAQ: SVRA · HEALTHCARE · BIOTECHNOLOGY
$5.12
-2.10% today
Updated 2026-05-11
Market cap
$1.06B
P/E ratio
—
P/S ratio
145,272.62x
EPS (TTM)
$-0.53
Dividend yield
—
52W range
$2 – $7
Volume
1.5M
Savara Inc (SVRA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-63.40%
ROA
-32.90%
Debt/equity
0.32x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-29.33M | — | — | — |
| 2007 | $500000.00 | $-22.14M | 100.00% | -4,862.21% | -4,428.41% |
| 2008 | $500000.00 | $-26.65M | 100.00% | -5,461.97% | -5,329.50% |
| 2009 | $300000.00 | $-11.33M | 100.00% | -3,761.90% | -3,775.02% |
| 2010 | $488959.00 | $-8.45M | 100.00% | -1,746.51% | -1,728.35% |
| 2011 | $0.00 | $-13.26M | — | — | — |
| 2012 | $0.00 | $-15.56M | — | — | — |
| 2013 | $0.00 | $-21.48M | — | — | — |
| 2014 | $1548.00 | $-28.70M | 100.00% | -1,891,408.27% | -1,854,134.37% |
| 2015 | $54.00 | $-39.84M | -270,270.37% | -72,912,962.96% | -73,781,481.48% |
| 2016 | $400000.00 | $-10.92M | 100.00% | -2,737.00% | -2,730.75% |
| 2017 | $0.00 | $-29.80M | — | — | — |
| 2018 | $0.00 | $-61.52M | — | — | — |
| 2019 | $0.00 | $-78.17M | — | — | — |
| 2020 | $257000.00 | $-49.62M | -13,533.46% | -19,182.88% | -19,305.45% |
| 2021 | $1000.00 | $-43.01M | -2,899,100.00% | -4,147,700.00% | -4,301,400.00% |
| 2022 | $0.00 | $-38.15M | — | — | — |
| 2023 | $0.00 | $-54.70M | — | — | — |
| 2024 | $0.00 | $-95.88M | — | — | — |
| 2025 | $0.00 | $-118.84M | — | — | — |